Redcare Pharmacy NV (RDC) — Cash Flow Reinvestment Rate

Latest as of June 2025: 5.41x

Redcare Pharmacy NV (RDC) has a Cash Flow Reinvestment Rate of 5.41x as of June 2025, reinvesting €178.96 Million (capex €36.81 Million plus investments €-142.14 Million) from operating cash flow of €33.10 Million. Check RDC cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

5.41x
(Capex + Investments) / Operating CF

Total Reinvested

€178.96 Million
Capex + Investments

Operating Cash Flow

€33.10 Million
EUR

Capital Expenditures

€36.81 Million
EUR

Redcare Pharmacy NV Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for Redcare Pharmacy NV across 5 annual periods. Explore how well can Redcare Pharmacy NV service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Redcare Pharmacy NV (2020–2025)

Year-by-year capital reinvestment analysis for Redcare Pharmacy NV. For live market cap and broader valuation context, see Redcare Pharmacy NV stock valuation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 4.88x €151.40 Million €31.00 Million €118.60 Million ▲ +37.7%
2024 3.55x €78.40 Million €22.10 Million €42.10 Million ▲ +378.3%
2023 0.74x €45.59 Million €61.46 Million €38.22 Million ▼ -46.8%
2021 1.40x €16.23 Million €11.63 Million €13.82 Million ▼ -51.6%
2020 2.88x €51.31 Million €17.80 Million €38.23 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow